We are live on
!
Find out more
Man Group Portfolio holdings
AUM
$55.1B
1-Year Est. Return
24.23%
This Fund
S&P 500
This Quarter
Est. Return
+13.53%
1 Year Est. Return
+24.23%
3 Year Est. Return
+82.67%
5 Year Est. Return
+105.49%
10 Year Est. Return
–
AUM
$35.9B
AUM Growth
+$3.63B
(+11%)
Cap. Flow
+$30.8B
Cap. Flow
% of AUM
85.82%
Top 10 Holdings %
Top 10 Hldgs %
15.31%
Holding
2,049
New
1,918
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.02B |
| 2 |
Apple
AAPL
|
+$825M |
| 3 |
NVIDIA
NVDA
|
+$552M |
| 4 |
TSMC
TSM
|
+$516M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$514M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.77% |
| 2 | Consumer Discretionary | 14.69% |
| 3 | Healthcare | 11.01% |
| 4 | Financials | 9.76% |
| 5 | Industrials | 7.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1851
W&T Offshore
WTI
$545M
| $127K | ﹤0.01% |
+39,100
| New | +$144K |
|
1852
Caribou Biosciences
CRBU
$156M
| $127K | ﹤0.01% |
+22,108
| New | +$109K |
|
1853
Tenaya Therapeutics
TNYA
$168M
| $125K | ﹤0.01% |
+38,540
| New | +$83.2K |
|
1854
Novavax
NVAX
$1.23B
| $125K | ﹤0.01% |
+25,999
| New | +$159K |
|
1855
Ginkgo Bioworks
DNA
$481M
| $124K | ﹤0.01% |
+1,836
| New | +$112K |
|
1856
Sana Biotechnology
SANA
$885M
| $122K | ﹤0.01% |
+29,800
| New | +$110K |
|
1857
Heritage Global
HGBL
$41.7M
| $121K | ﹤0.01% |
+43,643
| New | +$129K |
|
1858
Zedge
ZDGE
$38.9M
| $120K | ﹤0.01% |
+51,227
| New | +$103K |
|
1859
Personalis
PSNL
$1.26B
| $119K | ﹤0.01% |
+56,540
| New | +$73K |
|
1860
CEL-SCI Corp
CVM
$20.6M
| $117K | ﹤0.01% |
+1,431
| New | +$89.2K |
|
|
WW
1861
DELISTED
WW International
WW
| $113K | ﹤0.01% |
+12,888
| New | +$109K |
|
1862
Lifetime Brands
LCUT
$199M
| $112K | ﹤0.01% |
+16,714
| New | +$97.7K |
|
1863
Nerdy
NRDY
$107M
| $110K | ﹤0.01% |
+31,977
| New | +$98.1K |
|
|
ITOS
1864
DELISTED
iTeos Therapeutics
ITOS
| $110K | ﹤0.01% |
+10,005
| New | +$99.2K |
|
1865
Aclaris Therapeutics
ACRS
$730M
| $106K | ﹤0.01% |
+101,280
| New | +$309K |
|
1866
Journey Medical
DERM
$170M
| $105K | ﹤0.01% |
+18,268
| New | +$81.4K |
|
1867
Lyell Immunopharma
LYEL
$309M
| $105K | ﹤0.01% |
+2,710
| New | +$97.6K |
|
1868
CALL
Boeing
BA
$165B
| $104K | ﹤0.01% |
+400
| New | +$85.5K |
|
|
1869
PUT
Boeing
BA
$165B
| $104K | ﹤0.01% |
+400
| New | +$85.5K |
|
1870
Helix Energy Solutions
HLX
$1.46B
| $104K | ﹤0.01% |
+10,069
| New | +$100K |
|
|
MRSN
1871
DELISTED
Mersana Therapeutics
MRSN
| $103K | ﹤0.01% |
+1,784
| New | +$71.8K |
|
|
NGM
1872
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $103K | ﹤0.01% |
+119,740
| New | +$105K |
|
1873
Community Health Systems
CYH
$385M
| $102K | ﹤0.01% |
+32,600
| New | +$87.9K |
|
|
SELF
1874
Global Self Storage
SELF
$57.7M
| $102K | ﹤0.01% |
+21,994
| New | +$102K |
|
|
HAPN
1875
Happen Inc
HAPN
$2.08B
| $102K | ﹤0.01% |
+11,639
| New | +$73.1K |
|
Similar funds
Man Group's Q4 2023 Portfolio in Review
As of Q4 2023, Man Group held 2,049 positions worth $35.9B, up 11% from $32.3B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Man Group deployed $30.8B of net new capital in Q4 2023, opening 1,918 new positions. Its largest new stake was Microsoft: 2,865,670 shares worth $1.08B.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Man Group's largest Q4 2023 buy was Microsoft: 2,865,670 shares worth $1.08B.
- Man Group's ten largest holdings make up 15% of its $35.9B portfolio in Q4 2023.
- Man Group opened 1,918 new positions and closed 0 in Q4 2023.
- Man Group's portfolio value rose 11% quarter-over-quarter to $35.9B.
Based on Man Group's 13F filing for Q4 2023, filed 14 Feb 2024.